Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Furmacy
AddedMar 17, 2024
UpdatedJul 3, 2026
Furmacy

Furmacy

Acquired

Veterinary pharmacy services for pets, delivered to your door.

Founded
2020
Accelerator
Y Combinator logoY CombinatorW21
Overview
Compare
Fundraising
Employees

Furmacy, operating under the brand name Furscription, is dedicated to revolutionizing veterinary pharmacy services by providing digital e-prescribing software for veterinarians. Their core mission is to streamline the prescription process, making it secure and user-friendly for vet staff. Furscription allows veterinarians to e-prescribe to any pharmacy and manage script requests efficiently, eliminating the need for faxes, phone calls, and multiple portals. The service also includes features for prescribing controlled substances, reducing liability, and ensuring speedy scripting.

Furscription has significantly impacted the veterinary field by simplifying prescription management and enhancing operational efficiency for veterinary practices. By consolidating requests from all online and local pharmacies into one platform, Furscription has improved the workflow for vet staff, enabling them to focus more on patient care. The company's innovative approach has garnered attention and adoption across the veterinary community, positioning it as a key player in the digital transformation of veterinary services.

Furmacy - Similar Companies

VetRec logo

VetRec

vetrec.io

VetX logo

VetX

Vetsource logo

Vetsource

Vetcove logo

Vetcove

shop.vetcove.com

Dr.Tail logo

Dr.Tail

drtail.us

Vetnio logo

Vetnio

vetnio.com

AskVet logo

AskVet

askvet.app

Petvisor logo

Petvisor

VetCloud logo

VetCloud

Sanvivo logo

Sanvivo

sanvivo.eu

MedMe Health logo

MedMe Health

medmehealth.com

Petriage logo

Petriage

petriage.com

Mixlab logo

Mixlab

mixlabrx.com

Otto logo

Otto

Vet On Demand logo

Vet On Demand

Furmacy - Quick Facts

Who are Furmacy's competitors?

Companies similar to Furmacy include VetRec, VetX, Vetsource and Vetcove.

When was Furmacy founded?

Furmacy was founded in 2020.

When was Furmacy's last funding round?

Furmacy's most recent funding round was for $125k (USD) in January 2021.

How much has Furmacy raised to-date?

As of Jan 1, 2021, Furmacy has raised a total of $125k (USD).

Furmacy - Classification

Ownership
  • Venture Capital
Technology
  • Software
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprises
Main Product
  • Veterinary Software
Tags
  • SaaS
  • Veterinary